Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions
Lauren Walker, Leonidas Stefanis, Johannes Attems
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 467-474
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
Per Borghammer, Nathalie Van Den Berge
Journal of Parkinson s Disease (2019) Vol. 9, Iss. s2, pp. S281-S295
Open Access | Times Cited: 306
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 270
Impact of neurodegenerative diseases on human adult hippocampal neurogenesis
Julia Terreros‐Roncal, Elena P. Moreno‐Jiménez, Miguel Flor‐García, et al.
Science (2021) Vol. 374, Iss. 6571, pp. 1106-1113
Open Access | Times Cited: 221
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
Shareen Singh, Thakur Gurjeet Singh
Current Neuropharmacology (2020) Vol. 18, Iss. 10, pp. 918-935
Open Access | Times Cited: 199
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 196
Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals
Emilia Schwertner, Joana B. Pereira, Hong Xu, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 3, pp. 1307-1318
Open Access | Times Cited: 78
Inflammation in dementia with Lewy bodies
Jay Amin, Daniel Erskine, Paul C. Donaghy, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105698-105698
Open Access | Times Cited: 42
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Obada M. Alzghool, Guus A.M.S. van Dongen, Elsmarieke van de Giessen, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 936-948
Open Access | Times Cited: 39
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
Marta del Campo, Lisa Vermunt, Carel F.W. Peeters, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”
Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1127-1142
Open Access | Times Cited: 25
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer’s disease
Lauren Walker, H.E. Simpson, Alan Thomas, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution
Tanis J. Ferman, Naoya Aoki, Bradley F. Boeve, et al.
Neurology (2020) Vol. 95, Iss. 2
Open Access | Times Cited: 67
Depression in dementia with Lewy bodies: a critical update
K. A. Jellinger
Journal of Neural Transmission (2023) Vol. 130, Iss. 10, pp. 1207-1218
Closed Access | Times Cited: 17
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
Jon‐Anders Tunold, Manuela Tan, Shunsuke Koga, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4077-4087
Open Access | Times Cited: 16
Machine learning for the detection and diagnosis of cognitive impairment in Parkinson’s Disease: A systematic review
Callum Altham, Huaizhong Zhang, Ella Pereira
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303644-e0303644
Open Access | Times Cited: 7
Clinical drug development for dementia with Lewy bodies: past and present
Garam Lee, Jeffrey L. Cummings, Boris Decourt, et al.
Expert Opinion on Investigational Drugs (2019) Vol. 28, Iss. 11, pp. 951-965
Open Access | Times Cited: 44
The Neuropathological Diagnosis of Alzheimer’s Disease—The Challenges of Pathological Mimics and Concomitant Pathology
Andrew King, István Bódi, Claire Troakes
Brain Sciences (2020) Vol. 10, Iss. 8, pp. 479-479
Open Access | Times Cited: 42
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
Jacqui Nimmo, Ajay Verma, Jean‐Cosme Dodart, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
Sephira G. Ryman, Andrei A. Vakhtin, Sarah Pirio Richardson, et al.
Journal of Neurology (2022) Vol. 270, Iss. 2, pp. 746-758
Open Access | Times Cited: 26
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
K. A. Jellinger
Parkinsonism & Related Disorders (2022) Vol. 100, pp. 24-32
Closed Access | Times Cited: 24
Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
Carmen Peña‐Bautista, Rakesh Kumar, Miguel Baquero, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 15
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms
Lauren Walker, Johannes Attems
Journal of Parkinson s Disease (2023) Vol. 14, Iss. 1, pp. 35-52
Open Access | Times Cited: 15
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 6, pp. 639-661
Closed Access | Times Cited: 5
Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system
Noopur Bhore, Erin C. Bogacki, Benjamin O’Callaghan, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top